Antihypertensive effect of etamicastat in dopamine D2 receptor-deficient mice

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Hypertension Research

• Publication date

  2018-04-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41440-018-0041-5PMID 29654295PMCID PMC6503839
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of angiotensin II type 1 receptors increases D4 dopamine receptor expression in rat renal proximal tubule cells

  2017cited by this paper
• Sustained high blood pressure reduction with etamicastat, a peripheral selective dopamine β-hydroxylase inhibitor.

  2016cited by this paper
• Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure.

  2016cited by this paper
• Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat

  2015cited by this paper
• 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

  2014cited by this paper
• Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat

  2014cited by this paper
• Dopamine D3 receptor inhibits the ubiquitin‐specific peptidase 48 to promote NHE3 degradation

  2014cited by this paper
• Etamicastat, a novel dopamine β-hydroxylase inhibitor: tolerability, pharmacokinetics, and pharmacodynamics in patients with hypertension.

  2013cited by this paper
• Upregulation of Renal D5 Dopamine Receptor Ameliorates the Hypertension in D3 Dopamine Receptor–Deficient Mice

  2013cited by this paper
• Novel role of sorting nexin 5 in renal D1 dopamine receptor trafficking and function: implications for hypertension

  2013cited by this paper
• Deficient Dopamine D2 Receptor Function Causes Renal Inflammation Independently of High Blood Pressure

  2012cited by this paper
• Dopamine and renal function and blood pressure regulation.

  2011cited by this paper
• Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.

  2011cited by this paper
• Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study.

  2011cited by this paper
• Upregulation of Renal Sodium Transporters in D5 Dopamine Receptor–Deficient Mice

  2010cited by this paper
• Renal dopaminergic defect in C57Bl/6J mice.

  2009cited by this paper
• Dopamine receptors and hypertension

  2008cited by this paper
• Stopping stress at its origins: addressing working conditions.

  2007cited by this paper
• The elevated blood pressure of human GRK4gamma A142V transgenic mice is not associated with increased ROS production.

  2007cited by this paper
• Reactive Oxygen Species–Dependent Hypertension in Dopamine D2 Receptor–Deficient Mice

  2007cited by this paper
• Synthesis and biological evaluation of novel, peripherally selective chromanyl imidazolethione-based inhibitors of dopamine beta-hydroxylase.

  2006cited by this paper
• Dopamine β-Hydroxylase Knockout Mice have Alterations in Dopamine Signaling and are Hypersensitive to Cocaine

  2006cited by this paper
• Synthesis and Biological Evaluation of Novel, Peripherally Selective Chromanyl Imidazolethione-Based Inhibitors of Dopamine β-Hydroxylase

  2006cited by this paper
• Angiotensin-II Type 1 Receptor–Mediated Hypertension in D4 Dopamine Receptor–Deficient Mice

  2006cited by this paper
• An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension.

  2005cited by this paper
• Aberrant ETB receptor regulation of AT receptors in immortalized renal proximal tubule cells of spontaneously hypertensive rats.

  2005cited by this paper
• Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.

  2003cited by this paper
• Dopamine D2 Receptor Modulates Sodium Handling via Local Production of Dopamine in the Kidney

  2003cited by this paper
• Renal Dopamine Receptors and Hypertension

  2003cited by this paper
• Changes in Extracellular Dopamine Induced by Morphine and Cocaine: Crucial Control by D2 Receptors

  2002cited by this paper
• Adrenergic and Endothelin B Receptor-Dependent Hypertension in Dopamine Receptor Type-2 Knockout Mice

  2001cited by this paper
• Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism.

  2000cited by this paper
• Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors.

  1999cited by this paper
• Noradrenaline is essential for mouse fetal development

  1995cited by this paper
• Cell inward transport of l‐DOPA and 3‐O‐methyl‐l‐DOPA in rat renal tubules

  1994cited by this paper
• Involvement of tubular sodium in the formation of dopamine in the human renal cortex.

  1993cited by this paper
• Patients with Congenital Dopamine β-Hydroxylase DeficiencyA Lesson in Catecholamine Physiology

  1988cited by this paper
• Patients with congenital dopamine beta-hydroxylase deficiency. A lesson in catecholamine physiology.

  1988cited by this paper
• A comparison between the pattern of dopamine and noradrenaline release from sympathetic neurones of the dog mesenteric artery

  1987cited by this paper
• Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery

  1986cited by this paper
• Catecholamine metabolism: basic aspects and clinical significance.

  1985cited by this paper
• Renal nerves and catecholamine excretion.

  1981cited by this paper
• IMMUNOFLUORESCENCE OF DOPAMINE-β-HYDROXYLASE APPLICATION OF IMPROVED METHODOLOGY TO THE LOCALIZATION OF THE PERIPHERAL AND CENTRAL NORADRENERGIC NERVOUS SYSTEM

  1973cited by this paper

• Genomic data-driven framework for drug target discovery in atrial fibrillation

  2025cites this paper
• Renal CD81 interacts with sodium potassium 2 chloride cotransporter and sodium chloride cotransporter in rats with lipopolysaccharide‐induced preeclampsia

  2023cites this paper
• GYY4137, a H2S donor, ameliorates kidney injuries in diabetic mice by modifying renal ROS-associated enzymes.

  2023cites this paper
• Interactions between the intrarenal dopaminergic and the renin-angiotensin systems in the control of systemic arterial pressure.

  2022cites this paper
• Inverse Salt Sensitivity of Blood Pressure: Mechanisms and Potential Relevance for Prevention of Cardiovascular Disease

  2022cites this paper
• Effect of D4 Dopamine Receptor on Na+-K+-ATPase Activity in Renal Proximal Tubule Cells

  2022cites this paper
• Inverse Salt Sensitivity of Blood Pressure Is Associated with an Increased Renin-Angiotensin System Activity

  2022cites this paper
• Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications

  2021cites this paper
• [New perspectives in the management of arterial hypertension].

  2021cites this paper
• The Role of the Renal Dopaminergic System and Oxidative Stress in the Pathogenesis of Hypertension

  2021influential citation
• Reinvestigation of the tonic natriuretic action of intrarenal dopamine: comparison of two variants of salt‐dependent hypertension and spontaneously hypertensive rats

  2021cites this paper